Deep sequencing reveals abundant noncanonical retroviral microRNAs in B-cell leukemia/lymphoma

Viral tumor models have significantly contributed to our understanding of oncogenic mechanisms. How transforming delta-retroviruses induce malignancy, however, remains poorly understood, especially as viral mRNA/protein are tightly silenced in tumors. Here, using deep sequencing of broad windows of...

Full description

Saved in:
Bibliographic Details
Published inProceedings of the National Academy of Sciences - PNAS Vol. 110; no. 6; pp. 2306 - 2311
Main Authors Rosewick, Nicolas, Momont, Mélanie, Durkin, Keith, Takeda, Haruko, Caiment, Florian, Cleuter, Yvette, Vernin, Céline, Mortreux, Franck, Wattel, Eric, Burny, Arsène, Georges, Michel, Van den Broeke, Anne
Format Journal Article
LanguageEnglish
Published United States National Academy of Sciences 05.02.2013
National Acad Sciences
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Viral tumor models have significantly contributed to our understanding of oncogenic mechanisms. How transforming delta-retroviruses induce malignancy, however, remains poorly understood, especially as viral mRNA/protein are tightly silenced in tumors. Here, using deep sequencing of broad windows of small RNA sizes in the bovine leukemia virus ovine model of leukemia/lymphoma, we provide in vivo evidence of the production of noncanonical RNA polymerase III (Pol III)-transcribed viral microRNAs in leukemic B cells in the complete absence of Pol II 5′-LTR–driven transcriptional activity. Processed from a cluster of five independent self-sufficient transcriptional units located in a proviral region dispensable for in vivo infectivity, bovine leukemia virus microRNAs represent ∼40% of all microRNAs in both experimental and natural malignancy. They are subject to strong purifying selection and associate with Argonautes, consistent with a critical function in silencing of important cellular and/or viral targets. Bovine leukemia virus microRNAs are strongly expressed in preleukemic and malignant cells in which structural and regulatory gene expression is repressed, suggesting a key role in tumor onset and progression. Understanding how Pol III-dependent microRNAs subvert cellular and viral pathways will contribute to deciphering the intricate perturbations that underlie malignant transformation.
Bibliography:http://dx.doi.org/10.1073/pnas.1213842110
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 14
ObjectType-Article-1
ObjectType-Feature-2
content type line 23
1Present address: Department of Toxicogenomics, Maastricht University, 6200 MD Maastricht, The Netherlands.
Author contributions: M.G. and A.V.d.B. designed research; N.R., M.M., K.D., H.T., F.C., Y.C., and C.V. performed research; N.R., F.M., E.W., M.G., and A.V.d.B. analyzed data; and N.R., F.M., A.B., M.G., and A.V.d.B. wrote the paper.
Edited* by Robert C. Gallo, Institute of Human Virology, University of Maryland School of Medicine, Baltimore, MD, and approved December 14, 2012 (received for review August 21, 2012)
ISSN:0027-8424
1091-6490
1091-6490
DOI:10.1073/pnas.1213842110